Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Stevioside, a natural high-intensity sweetener, is widely employed across the food, pharmaceutical, and daily chemical industries due to its intense sweetness and health benefits. However, traditional extraction and purification processes for steviol glycosides from are plagued by low efficiency, high energy consumption, substantial environmental impact, and inconsistent product quality. This study systematically optimized the extraction, decolorization, decontamination, and desalting processes to overcome these challenges. The extraction method was refined using 20% ethanol as the solvent, an optimal temperature of 50 °C, and a 1:10 material-to-liquid ratio, increasing the steviol glycoside yield from 32.0% to 49.1%. Decolorization employing a combination of resins D940 and T5 achieved decolorization rates of 89-92% with minimized steviol glycoside loss, surpassing the non-selective adsorption limitations of activated carbon. For decontamination, calcium hydroxide (Ca(OH)) outperformed diatomaceous earth, attaining a 98% protein removal rate while maintaining steviol glycoside loss below 20%. The desalting resin LXP-016 demonstrated superior performance at 40 °C, enhancing the ability of ionic impurity removal. These optimizations collectively improve the efficiency, sustainability, and quality of steviol glycoside production, offering a promising framework for industrial-scale applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12388360PMC
http://dx.doi.org/10.3390/molecules30163416DOI Listing

Publication Analysis

Top Keywords

steviol glycoside
16
glycoside loss
8
steviol
5
ultrasound-assisted coupled
4
coupled resin-based
4
resin-based purification
4
purification sustainable
4
extraction
4
sustainable extraction
4
extraction steviosides
4

Similar Publications

Stevioside, a natural high-intensity sweetener, is widely employed across the food, pharmaceutical, and daily chemical industries due to its intense sweetness and health benefits. However, traditional extraction and purification processes for steviol glycosides from are plagued by low efficiency, high energy consumption, substantial environmental impact, and inconsistent product quality. This study systematically optimized the extraction, decolorization, decontamination, and desalting processes to overcome these challenges.

View Article and Find Full Text PDF

leaves and extracts need to be promptly dried after harvest to prevent microbial activity and preserve their bioactive compounds, including glycosides, flavonoids, and essential oils. Effective drying also reduces moisture and volume, which lowers packaging, storage, and transportation costs. Therefore, innovative drying methods are necessary to maintain stevia's physicochemical, sensory, and nutritional properties for functional food formulations.

View Article and Find Full Text PDF

Objectives: The aim of this study was to investigate the effect of Rebaudioside A (RebA) on acetylcholinesterase (AChE) immunoreactivity in cortical neurons of the rat brain. RebA is a steviol glycoside commonly used in the production of sweeteners. Beyond its application as a food additive for diabetes management, steviol glycosides have been shown to influence memory and learning processes.

View Article and Find Full Text PDF

The continuing need for taxonomic input in phytochemical research.

J Ethnopharmacol

August 2025

Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH, 43210, USA. Electronic address:

Ethnopharmacological Relevance: Correct taxonomic identification and depositing voucher herbarium specimens in an internationally recognized herbarium institution listed in the Index Herbariorum (https://sweetgum.nybg.org/science/ih/), such as the John G.

View Article and Find Full Text PDF

BCL-2 (B-cell lymphoma-2) is a key protein overexpressed in numerous cancers. Further, its association with cancer cell survival, prognosis, and ability to evade apoptosis makes it an important drug target in cancer chemotherapy. Venetoclax (ABP199) is the only FDA-approved BCL-2 inhibitor for chronic lymphocytic leukemia (CLL).

View Article and Find Full Text PDF